GlassScriptPhysician profile
Brittany Polizzi
NPI 1821692336
$34,706.13
in general payments reported to CMS, 2019-2025
28 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $480 · 2022: $2,043 · 2023: $3,871 · 2024: $14K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $11K · Consulting Fee: $5,382 · Travel and Lodging: $2,865 · Education: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,212.50 |
| Food and Beverage | $10,500.23 |
| Consulting Fee | $5,382.00 |
| Travel and Lodging | $2,865.03 |
| Education | $223.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $20,495.87 | 2021-2025 | Ebglyss, Taltz, Olumiant |
| Abbvie INC. | $4,726.05 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,994.06 | 2023-2024 | Sotyktu |
| Epi Health, LLC | $984.33 | 2022 | |
| Genzyme Corporation | $943.02 | 2022-2025 | |
| Arcutis Biotherapeutics, INC. | $686.69 | 2023-2025 | Zoryve |
| Dermavant Sciences, INC. | $681.81 | 2022-2024 | Vtama |
| Janssen Biotech, INC. | $581.50 | 2021-2025 | Tremfya, Simponi Aria, Remicade |
| Ucb, INC. | $520.97 | 2024-2025 | Bimzelx |
| Pfizer INC. | $495.35 | 2021-2025 | |
| Incyte Corporation | $401.39 | 2022-2025 | Opzelura |
| Amgen INC. | $340.63 | 2023-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $312.46 | 2022-2025 | Blu-U, Odomzo, Ilumya |
| Janssen Scientific Affairs, LLC | $247.63 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $243.43 | 2022-2025 | Libtayo, Dupixent |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $221.11 | 2022-2025 | Adbry |
| Galderma Laboratories, L.P. | $195.61 | 2022-2025 | Nemluvio, Aklief |
| Organon LLC | $193.32 | 2025 | Vtama |
| Eli Lilly and Company | $94.44 | 2024 | |
| Novartis Pharmaceuticals Corporation | $86.10 | 2025 | |
| Sanofi-Aventis U.S. LLC | $46.88 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $40.18 | 2022-2023 | Arazlo, Jublia |
| Biofrontera INC. | $38.95 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
| Almirall LLC | $37.44 | 2021-2023 | Klisyri |
| Merz North America, INC. | $26.07 | 2022 | |
| Revance Therapeutics, INC. | $24.14 | 2025 | Daxxify |
| Botanix Sb INC | $23.57 | 2025 | Sofdra |
| Verrica Pharmaceuticals INC. | $23.13 | 2023 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Polizzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.